Place of death and health care utilization for people in the last 6 months of life in Switzerland: a retrospective analysis using administrative data by Reich, Oliver et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2013
Place of death and health care utilization for people in the last 6 months of
life in Switzerland: a retrospective analysis using administrative data
Reich, Oliver; Signorell, Andri; Busato, André
Abstract: BACKGROUND: There is a growing interest in examining the current state of care and
identifying opportunities for improving care and reducing costs at the end of life. The aim of this study
is to examine patterns of health care use at the end of life and place of death and to describe the basic
characteristics of the decedents in the last six months of their life. METHODS: The empirical analysis is
based on data from 58,732 Swiss residents who died between 2007 and 2011. All decedents had mandatory
health insurance with Helsana Group, the largest health insurer in Switzerland. Descriptive statistical
techniques were used to provide a general profile of the study population and determinants of the outcome
for place of death were analyzed with an econometric approach. RESULTS: There were substantial and
significant differences in health care utilization in the last six months of life between places of death. The
mean numbers of consultations with a general practitioner or a specialist physician as well as the number
of different medications and the number of hospital days was consistently highest for the decedents who
died in a hospital. We found death occurred in Switzerland most frequently in hospitals (38.4% of all
cases) followed by nursing homes (35.1%) and dying at home (26.6%). The econometric analysis indicated
that the place of death is significantly associated with age, sex, region and multiple chronic conditions.
CONCLUSIONS: The importance of nursing homes and patients’ own homes as place of death will
continue to grow in the future. Knowing the determinants of place of death and patterns of health care
utilization of decedents can help decision makers on the allocation of these needed health care services in
Switzerland.
DOI: 10.1186/1472-6963-13-116
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: http://doi.org/10.5167/uzh-79784
Published Version
 
 
Originally published at:
Reich, Oliver; Signorell, Andri; Busato, André (2013). Place of death and health care utilization for
people in the last 6 months of life in Switzerland: a retrospective analysis using administrative data.
BMC Health Services Research, 13:116. DOI: 10.1186/1472-6963-13-116
RESEARCH ARTICLE Open Access
Place of death and health care utilization for
people in the last 6 months of life in Switzerland:
a retrospective analysis using administrative data
Oliver Reich1,2*, Andri Signorell1 and André Busato3,4
Abstract
Background: There is a growing interest in examining the current state of care and identifying opportunities for
improving care and reducing costs at the end of life. The aim of this study is to examine patterns of health care use
at the end of life and place of death and to describe the basic characteristics of the decedents in the last six
months of their life.
Methods: The empirical analysis is based on data from 58,732 Swiss residents who died between 2007 and 2011.
All decedents had mandatory health insurance with Helsana Group, the largest health insurer in Switzerland.
Descriptive statistical techniques were used to provide a general profile of the study population and determinants
of the outcome for place of death were analyzed with an econometric approach.
Results: There were substantial and significant differences in health care utilization in the last six months of life
between places of death. The mean numbers of consultations with a general practitioner or a specialist physician as
well as the number of different medications and the number of hospital days was consistently highest for the
decedents who died in a hospital. We found death occurred in Switzerland most frequently in hospitals (38.4% of
all cases) followed by nursing homes (35.1%) and dying at home (26.6%). The econometric analysis indicated that
the place of death is significantly associated with age, sex, region and multiple chronic conditions.
Conclusions: The importance of nursing homes and patients’ own homes as place of death will continue to grow
in the future. Knowing the determinants of place of death and patterns of health care utilization of decedents can
help decision makers on the allocation of these needed health care services in Switzerland.
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Background
Medical care in the final months of life account for a
considerable share of health care expenditures (HCE) in
comparison to other years [1-6]. Therefore, issues
around end-of-life health care have been gaining increasing
attention among both policy-makers and researchers.
Concerns have been raised over the substantial costs at
the end of life and high costs are often interpreted as a
result of unnecessary medical procedures trying to keep
people alive, irrespective of the preferences of patients and
their relatives. Previous research shows that a higher
volume of care in terms of higher spending and high-
intensity treatment in the last year of life does not produce
better outcomes for patients [7-12]. Various studies on
end-of-life care also focused on the aspect of place of
death and the factors associated with the site of death
[13-18]. Other studies have typically concentrated on the
relationship between age and health care expenditure
[19-24], partly revealing the importance of time-to-death
as an important determinant of future HCE [25-29].
Besides examining the location of death and health
expenditures, regional variations as well as health care
settings at the end of life have also been used to reflect
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inappropriate care settings as individuals are approaching
death. Studies of health care utilization in end-of-life care
differ between regional areas and have yielded interesting
results [30-34] such as differing utilization pattern
depending on available health service resources in rural
versus urban areas.
However, little information exists on how constantly
growing health care expenditures and health care
utilization are distributed across various places of death
for patients in Switzerland. Hence, there is a growing
interest in examining the current state of care in various
settings and there is a need to identify opportunities for
improvement and reducing costs at the end of life
without compromising the quality of care. To our
knowledge, only a few studies have investigated the
situation for end-of-life patients in Switzerland.
Colombier et al. [35] investigated the impact of population
ageing on HCE and concluded that proximity to death is
of marginal importance. Moreover, morbidity outweighs
mortality as a factor of higher HCE. Official data on the
place of death have not been updated by the Swiss Federal
Statistical Office (SFSO) since 1987. Therefore, Fischer
et al. [36] estimated predictors for the place of death in
Switzerland for the year 2001. Hospital deaths occurred
most frequently followed by homes for the elderly and
dying at home, implying that the relevance of homes for
the elderly as a site of death will increase in the future.
Two other studies examined the differences in end-of-life
decision-making [37,38] in Switzerland and the results
suggest that decision-making is related to cultural factors
and to the care setting where people die.
This study contributes to the debate on the future
development of end-of-life care using administrative
health data. The study aims to examine patterns of
health care use and place of death at the end of life and
explores the basic characteristics of the decedents in
their last six months of life.
Methods
Data source and sample
Our retrospective analysis is based on administrative
data from the health care insurance group Helsana, the
largest health insurer in Switzerland, which provides 1.3
million individuals with mandatory health insurance.
Individual information on the date of death was used as
the inclusion criteria for the analysis and the study
population comprised 58,732 Swiss residents who died
between 2007 and 2011. It is reasonable to assume that
this sample is highly reliable as administrative claims
data collected by insurers cover nearly all health care
invoices. Deaths due to accidents and suicides are not
included in our sample. Unfortunately this information
as well as clinical data (e.g. diagnosis or cause of death)
is not available in the Swiss health insurer database. We
examined health care use and cost for the entire cohort
of decedents for the six months immediately prior to
death in one of the years 2007 to 2011. A major aspect
was to examine where the insured person died; we
therefore classified decedents into three mutually
exclusive categories: (1) those who died in a hospital,
(2) those who died in a nursing home and (3) those
who died at home. Geographic classification of place of
death was drawn from yearly reports published by the
Swiss Federal Statistical Office (SFSO).
Descriptive analysis
Descriptive statistical techniques were used to provide a
general profile of the study population. These data were
presented as means and standard deviations (sd) in the
case of continuous variables and as percentages in case
of categorical variables. We excluded missing values
from our descriptive analyses and reported the number
of available records. We examined patterns of health
care use per decedent in the last six months of life for
the following indicators: physician visits, hospital days,
nursing home days, number of prescription drugs and
home care costs (this was used as a proxy for home care
visits given that data were available).
Furthermore, differences between the three groups
with respect to place of death in terms of demographics,
insurance coverage, morbidity and health care utilization
were analyzed with a nonparametric analysis of variance
(Kruskal-Wallis test for continuous variables and chi-square
tests for categorical variables). Cramer’s V was applied
in order to measure the association of the variables.
Modeling procedures
We developed several statistical models to evaluate the
major outcome of care during the last six months of life:
place of death. Place of death was defined according to
the aforementioned three categories.
In order to assess patient-level effects the following
independent variables were included in the models: age,
sex, supplementary private hospital insurance coverage,
place of residence (city, agglomeration, rurala), insurance
contract under a managed care model, deductible class,
and number of chronic medical conditions identified
using pharmaceutical cost groups (PCG). Deductibles
are obligatory for all Swiss residents and range from 300
to 2,500 Swiss francs per year. The standard deductible
is 300 Swiss francs, but insured persons can choose a
higher deductible (500, 1500, 2000, 2500 Swiss francs) in
exchange for reduced premiums. PCGs are frequently
used as an individual marker for a specific chronic
condition [39]. Our classification of PCGs is based on
Beck [40] and distinguishes between 13 different groupsb.
We summarized all PCGs for each individual and coded
an independent dummy variable as 1 for three or more
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chronic conditions and 0 for less than three chronic
conditions. Furthermore, the intensity of medical treat-
ment for each individual patient was captured. These
variables describe health care utilization in the last six
months of life per decedent: number of consultations
with a general practitioner, number of consultations
with a specialist physician, number of days in hospital,
length of stay in days in nursing home, number of differ-
ent ATC (Anatomical Therapeutic Chemical) codesc
prescribed (outpatient only) and home care costs. To
take into account differences between Latin i.e. French-
or Italian-speaking cantons (Fribourg, Geneva, Jura,
Neuchatel, Ticino, Vaud and Valais) and German-
speaking cantons, we included a dummy variable (1 if
Latin canton, 0 if otherwise).
Associations between place of death and patient-level
variables were assessed by means of a multinomial
logistic regression. We used a log transformation of the
independent variablesd to estimate the effects. Equation
(1) depicts the model used:
log hP hYi ¼ k i
P hYi ¼ 0 i i ¼ β0 þ β1 AGEi þ β2 SEXiþβ3 PRIVi þ β4 MCi
þβ5 DEDi þ β6 REGi
þβ7 MMORBi þ β8 ATCi
þβ9 log GP þ 1ð Þi
þβ10 log SPEC þ 1ð Þi
þβ11 log HOMC þ 1ð Þi
ð1Þ
Where:
Y: Place of death, where dying at home is the according
reference value
AGE: Age at time of death in years
SEX: Sex of patient: dummy variable equal to 1 if
decedent was female and 0 if male
PRIV: Supplementary private hospital insurance:
dummy variable equals 1 if decedent possessed
additional private hospital insurance coverage and 0 in
all other cases
MC: Managed care health plan type: dummy variable
equals 1 if member chose a managed care health plan
and 0 in all other cases
DED: Deductible class: dummy variable equals 1 if
insured person chose a deductible higher than Swiss
francs (CHF) 500 and 0 in all other cases
REG: Region: we defined two dummy variables
according to the domicile of the insured person, where
the city is the according reference value:
Agglomeration area of residence = AGGLO: dummy
variable equals 1 if insured person lives in the
agglomeration and 0 in all other cases; Rural area of
residence = RURAL: dummy variable equals 1 if insured
person lives in a rural area and 0 in all other cases
MMORB: Multiple chronic conditions: dummy variable
equals 1 if insured person showed more than two
chronic conditions and 0 in all other cases
ATC: Number of different medications
GP: Number of consultations with a general
practitioner GP
SPEC: Number of consultations with a specialist
physician
HOMC: Costs of home care
The strength of associations was measured by the odds
ratio (OR) and the respective 95% confidence intervals
(CI). Interaction terms of importance were assessed and
when significant, a stratified analysis was performed. We
estimated a model with patient-level predictors in order
to quantify the relative contributions of patient-level
characteristics to the place of death. The proportion of
variance was defined as McFadden adjusted R-square for
the logistic regression; this is helpful in the model building
stage as a statistic to evaluate competing models. An
assessment of the total model quality was obtained by
taking the highest amount of explained variance of the
outcome variable.
Results
Population characteristics
Table 1 presents sample characteristics of the 58,732
decedents included in our analysis. Women accounted
for 53.6% of the total study population. The mean age at
time of death was 79.3 years (median 83.0). For women,
the mean age of death was 82.2 years (median 82.2), for
men 76.0 years (median 76.0). There were differences
between the shape of the distribution of age at time of
death between the sexes. Men show a larger variability
(standard deviation 14.9, interquartile range (IQR) 17)
compared to women (sd 13.1, IQR 14).
In terms of the patients’ characteristics and type of
additional insurance coverage by place of death, 19.1%
of the decedents had supplementary private hospital
insurance coverage, 5.5% had a deductible higher than
CHF 500 and 9.0% were enrolled in a managed care
insurance scheme. 33.5% of the study population lived in
a city, 42.8% in an agglomeration and 23.6% in a rural
area. 25.2% lived in a Latin canton and 74.8% in a
German-speaking canton. Individuals with more than
two chronic conditions accounted for 18.5% of the study
population.
With regard to place of death, individuals who died in
hospitals accounted for 38.4%, in nursing homes for 35.1%,
and those at home for 26.6% of the total. Considerable
and significant variation of site of death was observed
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between cantons (Figure 1). The proportion of people
dying at home for example varies between cantons from
22.1% in Ticino TI to 33.3% in Aargau AG (p < 0.001).
We observed a significant difference in age of death
with reference to the place of death. People dying in
nursing homes were on average 87.0 years old, people dying
at home 73.4 years (difference of 13.6 years, p < 0.002).
The difference in age between patient gender remains
clear. Men dying at home were 6.3 years younger than
women dying at home; in nursing homes the difference
amounted to 3.2 years (Table 2). A far greater proportion
of women died in nursing homes (45.0%) than men
(23.6%), whereas 43% of men died in a hospital and 33.1%
at home.
The enrollment in a supplementary hospital insurance
scheme was associated with hospital as the place of
death. 47.3% of the patients with supplementary coverage
died in a hospital. With reference to regional differences,
we also observed a lower proportion of patients dying at
home in Latin cantons. In those cantons the proportion of
people dying in a hospital was slightly higher (43.4% vs.
36.7% in German-speaking cantons). Patients with a high
deductible were younger on average (p < 0.001), which
accounts for the relatively small proportion of 13.9% of
patients choosing high deductibles who died in a
nursing home.
In general, all observed variables showed a significant
association with the place of death. However, the strength
of association measured with Cramer’s V illustrates very
moderate values (range between 0.00 and 0.22).
Health care utilization in the last six months of life
We observed mean HCE of 17,686 CHF during the last
six months of patients’ lives, with great variability when
stratifying for place of death (Table 3). Mean HCE for
people dying at home (CHF 11,194) were half as high
compared to people dying in hospitals (CHF 23,193).
The HCE for people dying in nursing homes lay between
these figures (CHF 16,579). Turning to the number of
consultations with a general practitioner, we observed a
mean of 2.9 consultations, whereas the average number
of consultations with a specialist physician was 0.8 in
the last six months of life. 55.1% of all patients had at
least one consultation with a GP and 26% at least one
consultation with a specialist physician. The number of
people consulting a GP shows considerable differences
in the observed groups. While staying in nursing homes,
only every third decedent visited a GP, 68.6% of patients
in the hospital group did so.
A total of 60.8% of all insured had a hospital stay
during their last six months of life. The mean duration
of stay for all decedents in our sample was 16.9 days.
When only considering patients who actually had a stay
in hospital, the mean duration was 27.7 days. Here as
well, the large difference between the mean lengths of
stay (LOS) regarding place of death is primarily caused
by people not having a hospital stay. The mean LOS
changes from 9.7 (at home) to 25.2, when excluding
patients without a hospital stay, which again is in the
range of the mean LOS of people dying in hospital
(29.0). The mean number of nursing home days was 58.3.
Mean home care costs amounted to CHF 766.9. In terms
of the number of different drugs consumed (measured by
counting distinct ATC codes), the difference between
place of death is small, as only around 15.1% of patients
Table 1 Descriptive patient characteristics included in
analysis, 2007-2011
Total Place of
death
pa)
Home Hospital Nursing
home
n 58,732 15,597 22,532 20,603
proportion 1.000 .266 .384 .351
Age
mean 79.3 73.4 76.5 87.0 ***
sd 14.3 17.5 13.2 8.2
Sex (in%)
Male .464 .331 .433 .236 ***
Female .536 .209 .341 .450
Deductible class (in%)
Low .945 .256 .381 .363 ***
High (> Swiss francs 500) .055 .434 .427 .139
Managed care plan (in%)
No .901 .263 .381 .355 ***
Yes .099 .285 .403 .312
Private hospital insurance
(in%)
No .809 .264 .363 .374 ***
Yes .191 .274 .473 .253
Type of residence (in%)
City .335 .249 .384 .367 ***
Agglomeration .428 .264 .394 .342
Rural area .236 .292 .364 .344
Multiple chronic condition
(in%)
No .815 .273 .352 .375 ***
Yes (>2 conditions) .185 .234 .523 .242
Latin canton (in%)
No .748 .275 .367 .358 ***
Yes .252 .238 .434 .329
Latin cantons include the cantons Fribourg, Geneva, Jura, Neuchatel, Ticino,
Vaud and Valais * P < 0.10, ** P < 0.05, *** P < 0.01.
a) Significance level: Kruskal-Wallis-test was used to check for significant
differences in age, chi-square-test for differences in the categorical variables.
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did not require any medication. On average, patients were
using 11.3 different medications, with a range of 9.5 to
13.5 with reference to place of death (Table 3).
Place of death
We evaluated the relationship between patient-level
characteristics and place of death by means of a
multivariate logistic regression model. Table 4 illustrates
the OR estimates of the model. The reference of place of
death is in each case “home”. The decedent-level variables
included in our model account for 17.9% of the variatione
of place of death.
Place of death was significantly associated with age,
sex, region and multi-morbidity. An elderly woman is
more likely to die in a nursing home, whereas a younger
man is more prone to die at home. A decedent living in
a rural area will presumably die at home and a person in
the city in hospital or in nursing home. Multi-morbid
patients have a much higher probability of dying in an
institution than at home (Hospital death OR 1.306, CI
[1.233 to 1.385]; nursing home death OR 1.376, CI
[1.279 to 1.480]). Furthermore, the crude numbers of
ATC codes are associated with a higher probability of
dying either in a hospital or a nursing home. High costs
for nursing are associated with a higher probability of
dying at home. All of the three insurance variables
(private supplementary hospital insurance, managed care
health plan and high deductible) are highly significant.
Private supplementary hospital insurance coverage
shows a higher OR for hospital death, but a decreased
probability of dying in a nursing home compared to
home. Decedents passing away at home seem to have
higher deductibles and are more likely to be enrolled in
a managed care health plan compared to decedents who
died in an institution. A somewhat contradictory picture
is found in terms of number of GP and specialist
physician consultations. Both predictors were significantly
associated with a higher probability of dying in a hospital.
Kartengrundlage:
(c) BFS, ThemaKart, 2013
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Regional variation of site of death at home
in Switzerland 2007−2011
(CH mean = 26.6%)
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Fribourg (FR), Geneva (GE), Glarus (GL), Grisons (GR), Jura (JU), Lucerne (LU), Neuchatel (NE), Nidwalden (NW), 
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Figure 1 Regional variation of site of death at home in Switzerland, 2007–2011.
Table 2 Proportion of patients according to place of
death and gender, 2007-2011
Place of death
Home Hospital Nursing home
n 15,597 22,532 20,603
proportion .266 .384 .351
Males
Mean age 70.7 75.2 84.8
n 9,007 11,787 6,436
in% .153 .201 .110
Females
Mean age 77.07 77.8 88.0
n 6,590 10,745 14,167
in% .112 .183 .241
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They were also both associated with lower risks of dying
in a nursing home.
Discussion
We found death occurred in Switzerland most frequently
in a hospital (38.4% of all cases) followed by nursing
homes (35.1%) and dying at home (26.6%), which is
generally consistent with other published data [36].
Nearly 26% of men died at home versus 20.9% for
women. However, 45% of women died in a nursing
home compared to 23.6% of men. We suppose that
this fact could mainly be attributed to the higher life
expectancy of women. Men can often live longer at
home due to the presence of a usually younger partner.
They tend to die in hospital after an acute deterioration of
their health state. Females spend their last phase of life
more frequently without a partner in a nursing home.
Additionally, we explored the association of place of death
and residential region. People in French- or Italian- speak-
ing cantons appeared to pass away to a greater extent in
hospitals (43.4%) than the Swiss average (nursing home
32.9% and home 23.8%). Fischer et al. [36] investigated the
place of death in 2001 only in the German speaking part
of Switzerland. In comparison with their results, our study
found a trend towards dying at home and a shift within
institutions from hospitals to nursing homes in the
German-speaking part of the country. Similarly, we
observed other significant regional differences between
age at death among Swiss cantons. This finding is
consistent with official data from the SFSO. Further
research is needed to determine the extent to which these
regional differences are due to patient preferences,
supplier-induced demand, differential access to medical
services or other factors.
There were substantial and significant differences in
the descriptive comparison of health care utilization in
the last six months of life between places of death. The
mean number of consultations with a general practitioner
or specialist as well as the number of different medications
and, naturally, the number of days in hospital was consist-
ently highest for the decedents in hospitals. This result
can be expected given the generally higher burden of
severe illnesses suffered by hospitalized patients. On the
other hand, the mean number of consultations with a
general practitioner as well as a specialist physician for
decedents in nursing homes might not be visible in health
insurance data due to aggregated claims data. Therefore,
these estimates are possibly biased.
The mean number of different medications consumed
by decedents is comparably high in our sample and
Table 3 Sample characteristics on health care utilization variables, 2007-2011
Total Place of death Home Hospital Nursing home pa)
Health care expenditures mean (CHF) 17,686.7 11,194.3 23,193.7 16,579.0 ***
Standard deviation 15,719.1 13,700.5 19,698.9 8,462.3
Proportion with values (%) 98.3 93.7 100.0 100.0
GP consultations mean 2.9 3.0 3.8 1.9 ***
Standard deviation 4.5 4.4 4.7 4.2
Proportion with values (%) 55.1 58.6 68.6 37.8
Specialist consultations mean 0.8 0.8 1.2 0.3 ***
Standard deviation 2.5 2.7 2.9 1.6
Proportion with values (%) 26.0 27.4 36.3 13.8
Length of stay hospital mean 16.9 9.7 29.0 9.0 ***
Standard deviation 25.6 19.3 30.0 18.5
Proportion with values (%) 60.8 38.7 99.9 34.7
Length of stay nursing home mean 58.3 14.2 16.7 137.1 ***
Standard deviation 74.8 42.0 45.1 53.0
Proportion with values (%) 45.6 15.1 17.4 99.5
Home care costs mean (CHF) 766.9 1,265.7 832.4 317.8 ***
Standard deviation 2,369.1 3,357.0 2,221.7 1,294.6
Proportion with values (%) 28.8 36.1 36.8 14.4
Different ATC-codes mean 11.3 10.6 13.5 9.5 ***
Standard deviation 8.8 9.1 8.8 8.1
Proportion with values (%) 84.9 84.4 93.8 75.5
CHF indicates Swiss francs; GP, general practitioner; ATC, Anatomical Therapeutic Classification * P < 0.10, ** P < 0.05, *** P < 0.01.
a) Significance level: Kruskal-Wallis-test was used to check for significant differences between the groups.
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there is considerable variation, mainly due to people
who had no medication at all. Differences in this variable
arise when splitting the sample by place of death. In
nursing homes we observed an unexpectedly high
percentage of people without any medication (24.5%).
This number of decedents without any medication might
be overestimated as we do not possess any information on
medication prescribed in nursing homes.
The majority of people had at least one stay in hospital
(60.8%) in the last six months of life and the average
length of stay was 16.9 days. However, the differences
between the places of death are highly influenced by the
number of persons having no stay at all. When
restricting the analysis to persons with at least one stay,
the mean LOS appeared similar across places of death
(27.7 days). The significant duration of hospital stays
(25.2 days) for those prior to dying at home was notable.
This could point towards the general preference of home
as place of death found in prior research [41,42].
Concomitantly and consistent with high expenditures
for hospital stays, last six-month HCE are significantly
affected by place of death. The mean HCE for hospital
deaths, at CHF 23,193.70, is more than twice the mean
amount for those dying at home (CHF 11,194.30) and
40% greater than the mean amount for nursing homes
(CHF 16,579.0).
Table 4 Results of the multinomial logistic regression analysis for decedents in Switzerland regarding “place of death”
(reference value: death at home), 2007-2011
Coefficient (SE) Odds ratioa) 95% confidence interval
hospital : AGE 0.012 (0.001)*** 1.012 1.011 1.014
hospital : SEX (female) 0.173 (0.022)*** 1.188 1.139 1.240
hospital : PRIV (additional private hospital insurance) 0.102 (0.027) *** 1.107 1.051 1.167
hospital : MC (managed care plan) −0.095 (0.035)** 0.910 0.850 0.974
hospital : DED (deductible class > Swiss francs 500) −0.153 (0.042)*** 0.858 0.791 0.932
hospital : REG_AGGLO (living in agglomeration) −0.061 (0.025)* 0.941 0.896 0.988
hospital : REG_RURAL (living in rural area) −0.217 (0.029)*** 0.805 0.761 0.852
hospital : MMORB (> 2 chronic conditions) 0.267 (0.030)*** 1.306 1.233 1.385
hospital : log(ATC + 1) 0.318 (0.013)*** 1.375 1.339 1.411
hospital : log(GP + 1) 0.097 (0.012)*** 1.102 1.076 1.129
hospital : log(SPEC + 1) 0.113 (0.017)*** 1.120 1.083 1.158
hospital : log(HOMC + 1) −0.058 (0.003)*** 0.944 0.938 0.950
nursing home : AGE 0.098 (0.001)*** 1.103 1.100 1.106
nursing home : SEX (female) 0.626 (0.025)*** 1.871 1.780 1.965
nursing home : PRIV (additional private hospital insurance) −0.253 (0.033)*** 0.777 0.728 0.828
nursing home : MC (managed care plan) −0.084 (0.041)* 0.919 0.848 0.997
nursing home : DED (deductible class > Swiss francs 500) −0.982 (0.064)*** 0.375 0.331 0.424
nursing home : REG_AGGLO (living in agglomeration) −0.012 (0.029) 0.988 0.934 1.044
nursing home : REG_RURAL (living in rural area) −0.112 (0.033)*** 0.894 0.838 0.954
nursing home : MMORB (> 2 chronic conditions) 0.319 (0.037)*** 1.376 1.279 1.480
nursing home : log(ATC + 1) 0.130 (0.014)*** 1.139 1.109 1.170
nursing home : log(GP + 1) −0.340 (0.014)*** 0.712 0.692 0.732
nursing home : log(SPEC + 1) −0.557 (0.025)*** 0.573 0.546 0.602
nursing home : log(HOMC + 1) −0.213 (0.004)*** 0.808 0.802 0.815
McFadden adjusted R2: 0.17865
Insample class. error rate 41.38%
AIC 104937.1
AGE indicates age at time of death; SEX, sex of patient; PRIV, supplementary private insurance; MC, managed care health plan; DED, deductible class; REG_AGGLO,
agglomeration area of residence; REG_RURAL, rural area of residence; MMORB, multiple chronic conditions; ATC, number of different medications; GP, number of
consultations with a general practitioner; SPEC, number of consultations with a specialist physician; HOMC, costs of home care.
Standard error (SE) in parentheses.
* P < 0.10, ** P < 0.05, *** P < 0.01.
a) The regression analysis determines the regression coefficient β of each independent variable. In order to obtain the OR of the variables, the coefficients are
transformed with exp (β).
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Our further analyses are in line with Kelley et al. [32]
and show that a substantial portion of the previously
described variations in place of death are due to
patient-level characteristics. Notably, the proportion
of variation explained by our model after patient
characteristics were controlled for is however larger
than the results presented by Kelley et al.. Place of death is
significantly associated with age, sex, region and multi-
morbidity. Elderly females have a greater probability of
dying in a nursing home, whereas a young male would
preferably die at home. Additionally, a decedent living in a
rural area will presumably die at home and people in
urban areas either in a hospital or nursing home. Persons
with multiple chronic conditions have a greater chance of
dying in an institution than at home. These findings are in
line with earlier studies [14,36,43].
Strengths and limitations
This study has several strengths. To our knowledge, it is
the first empirical investigation, which describes the
conditions and health care utilization in the last six
months of life with regard to place of death in
Switzerland. We use health insurance claims data, which
guarantees a uniform data set and presents an ideal basis
for the analysis. This study has focused primarily on
differences in place of death and health care utilization
at the end-of-life, but we cannot comment on the appro-
priateness of different patterns of care delivered to
decedents. In addition, our analysis is based on a period
of five consecutive years, which allows us to capture any
time effects as well as to reduce standard errors on the
interesting variables due to a larger sample.
It is also important to point out to some limitations of
our study. From previous unpublished research, we
estimate that 2-3% of all claims invoices are paid directly
by the patient (e.g. due to high deductibles chosen) and
are not reimbursed by the health insurer. This may lead
to a possible bias due to a mixture of the different effects
in the estimations and missing claims data. Furthermore,
we focused on all cases within the mandatory health
insurance in Switzerland, which omits people dying from
an accident or committing suicide, as these cases might
be covered by other insurance policies and the health
insurer does not see any referral claims. The claims
coming from nursing homes are often set at a flat rate and
lack further detailed information. This fact prevented us
from observing any medication or medical treatment
applied in the nursing home. Therefore, we suppose a
slight tendency to underestimate all variables describing
health care utilization for people residing in nursing
homes. This restriction does not notably affect treatment
outside nursing homes (consultations with GPs, out-
patient units, pharmacies etc.). To conclude, the place of
death is specified by means of the last claim received. The
claims contain the date and the duration of the specific
treatment, which allows us to compare it with the date of
death. The origin of the last claim then defines the place
of death. If there are several claims covering the date of
death, hospital is taken as place of death. This process
makes our data vulnerable to inaccuracies resulting from
administrative processes and might lead to a possible
overestimation of hospital deaths.
Conclusion
The importance of nursing homes and patients’ own
homes as the place of death will continue to grow in the
future. Various international studies confirm this shift,
especially towards people’s homes [18,41,42,44]. In order
to cope with the growing needs for end-of-life care for
ageing populations, the availability of community end-of-life
care and non-acute care inpatient facilities must be
substantially increased in Switzerland. Knowing the
determinants of place of death and patterns of health
care utilization of decedents can help decision makers
on the allocation of these needed health care services.
The study will provide useful data to guide further
research and development in this area.
Endnotes
aClassification according to the Swiss Federal Statistical
Office (SFSO).
bAsthma/chronic obstructive pulmonary disease (COPD),
epilepsy, rheumatism, cardiac disorders, Crohn’s disease/
ulcerative colitis, gastric disorders, diabetes types I and II,
Parkinson’s disease, transplants, cancer, HIV/AIDS and
kidney disorders.
cWHO Anatomical Therapeutic Chemical (ATC) clas-
sification system (WHO Collaborating Centre for Drug
Statistics Methodology: Guidelines for ATC classification
and DDD assignment 2011. Oslo; 2010).
dSince dummy variables are dichotomous, a log-
transformation makes no sense and is therefore not
performed for these independent variables.
eAccording to Hosmer and Lemeshow (2000, p. 167)
low R-square values are the norm in logistic regression
(Hosmer DW, Lemeshow S: Assessing the Fit of the
model. In Applied Logistic Regression. 2nd edition. New
York: Wiley; 2000:167).
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